Benson Hill, Inc. announced that Susan Keefe has been appointed Chief Financial Officer, effective March 29, 2024. Keefe succeeds Dean Freeman, who is leaving the company to pursue other opportunities. Freeman will continue to serve in the role through March 29, 2024, to ensure a smooth transition of responsibilities.

Keefe is a seasoned enterprise leader with deep life sciences and biotechnology industry experience in both public and private companies. Most recently, she served as Chief Financial Officer of GreenLight Biosciences, a biotech and ag tech company specializing in RNA-based solutions for agriculture and human health applications. Prior to joining GreenLight Biosciences, Keefe served as Chief Financial Officer, Vice President Finance of Danforth Advisors from 2018 to 2019, and previously as Vice President, Finance and Administration and Corporate Treasurer of Aushon Biosystems from 2013 to 2018.

Earlier in her career, Keefe held a variety of financial leadership positions across several organizations, including SeraCare Life Sciences, The Proctor & Gamble Company, and PricewaterhouseCoopers. Keefe holds an MBA in Strategic Management, Marketing, Finance and Entrepreneurship from The University of Chicago, Booth Graduate School of Business, and a Bachelor of Business Administration from the University of Iowa.